Thoroughly knowledgeable,
very pragmatic and

Chambers Guide


Keep up to date with our latest insight pieces, news and industry developments. See below for the latest posts or use the categories to hone your search for stories of interest.

Rather listen? The WABChats Podcast provides engaging and informative conversations with contacts, clients, advisors and friends of White & Black Limited. Listen Now.

White & Black Advise Ability Matters Group on acquisition of ProActive Prosthetics

White & Black Corporate Team is pleased to have recently advised Ability Matters Group on the acquisition of ProActive Prosthetics.

White & Black Advise Ability Matters Group on acquisition of ProActive Prosthetics

ProActive Prosthetics is an independent healthcare company delivering a best practice interdisciplinary approach for the rehabilitation of new and existing amputees. They aim to combine a patient need for quality products, comfort, capability and a cosmetic look with a caring and dedicated approach.

Whilst ProActive will continue to provide the same individual, professional and caring services, this acquisition will also bring the company access to the Ability Matters Group cutting-edge technologies and support the continued development of their services.

The team at ProActive will remain the same with founder Richard Nieveen continuing to lead the company.

Corporate transactional work is the largest area of our practice, with deals ranging from £1m to £750m, including mergers and acquisitions, finance, joint ventures, corporate governance, and banking involving high growth and pure technology companies. We guide our clients through every aspect, through to post-deal integration. Please reach out to Jonathan Williamson or John Allen from the White & Black Corporate Team for more information.

Disclaimer: This article is produced for and on behalf of White & Black Limited, which is a limited liability company registered in England and Wales with registered number 06436665. It is authorised and regulated by the Solicitors Regulation Authority. The contents of this article should be viewed as opinion and general guidance, and should not be treated as legal advice.

This site uses cookies to improve your user experience. By using this site you agree to these cookies being set. To find out more see our cookies policy